Feature Articles

Feature Articles

ASH Clinical News takes a deeper look at hot topics in medicine

Calculating the Costs of Clinical Trials

Patients eager to contribute to research may not be fully aware of the hidden costs of trial participation Of the three potential risks of participating...

Pediatric Hematology/Oncology: A Small Specialty Experiencing Big Changes

When Mona D. Shah, MD, MBA, finished her medical training in pediatric hematology/oncology in 2007, she estimated that most of her fellow trainees went...

Mainstreaming Alternative and Complementary Medicine

While some treatments for hematologic conditions such as sickle cell disease (SCD) and cancer, have been refined over time – increasing survival rates and...

Staging the Aging

Routine assessment of frailty can help clinicians tailor treatments and supportive care to an individual patient’s needs Hematologic malignancies are often diseases of older adults...

The Other Opioid Epidemic

Federal crackdowns on opioid prescribing have shifted the crisis from overdoses to undertreatment The United States is in the grip of an opioid epidemic that...

Breakthroughs for Bleeding: Updates in Treating and Managing Hemophilia

In 1982, the gene encoding factor IX (FIX) was cloned, followed by the cloning of the factor VIII (FVIII) gene in 1984. The events...

What Does the Future Hold for Gene Therapy in Nonmalignant Hematology?

The human genome contains about 25,000 genes that encode myriad proteins that drive the processes necessary for life. But disruptions, deletions, and mutations can...

Taking the Pulse of Health Care and Politics

With more health-related topics becoming politicized, it may be hard to keep politics out of the exam room. As another U.S. presidential election approaches, Americans...
Research espionage

The Spy Next Door?

Academic institutions and government organizations strive to prevent research espionage while maintaining open scientific collaborations For decades, the U.S. has fostered international research collaborations with...
In Myleloma, New Drugs, Skyrocketing Price Tags

In Myeloma, New Drugs, Skyrocketing Price Tags

In late February, seven pharmaceutical executives were called before the U.S. Senate Finance Committee to testify about the prices of brand-name prescription drugs, which...
Advertisement

Current Issue

December 2019, Volume 5, Issue 15

This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.